Dr. Nitish Mehta, MD

Dr. Mehta practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Mehta's NPI, 1174939656, was assigned on July 7, 2014. Dr. Mehta graduated from University of Massachusetts Medical School in 2014. Dr. Mehta holds New York license 280712.

Dr. Mehta's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-3130.

Dr. Mehta's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Mehta is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Mehta to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Mehta is licensed in New York.

CMS data shows 6,195 Medicare services from Dr. Mehta across 14 procedure codes in 2024, for 596 Medicare patients. Medicare paid $448,316 for them. Every service was in an office.

CMS counts 596 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 251 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 64, with 59% women.

In 2024, Dr. Mehta wrote 912 Medicare Part D claims for 261 patients. 58% of them were for generic drugs. CMS names the drug for 767 of them, across 18 drugs with 11 or more claims each, at $225,692 in total drug cost. In 2023, CMS named 586 claims across 17 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Mehta, published from 2014 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Diabetic Retinopathy and Retina. Dr. Mehta has published most often in J Vitreoretin Dis. Dr. Mehta's most frequent co-authors are Joel S. Schuman, MD, Roomasa Channa, MBBS and Vaidehi Shradha Dedania, MD.

CMS Open Payments shows 75 general payments to Dr. Mehta from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. Allergan Inc. paid the most, $5,978. It also lists 36 research payments totaling $12,537 from 2022 to 2025, naming 1 clinical trial.

Dr. Mehta graduated from University of Massachusetts Medical School in 2014.